AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

Dave & Buster's Charts Have Weakened

Bruce Kamich

We still have our reservations about the stock.

The Trade Desk Needs to Build a New Base Pattern

Bruce Kamich

The shares have bounced recently but have so far stopped at the underside of the declining 50-day moving average.

AquaBounty Technologies Continues to Struggle on the Charts

Bruce Kamich

Avoid the long side of AQB.

I'll Take a Pass on Kadmon Holdings

Bruce Kamich

KDMN has been stuck in a trading range.

Shares of L Brands Look Likely to Trade Sideways From Here

Bruce Kamich

New highs may have to wait for a while.

IBM Shares Could Surprise on the Upside This Year

Bruce Kamich

Let's check out the charts and indicators of Big Blue.

How to Trade Chewy After Earnings

Bruce Kamich

Here's what the latest charts and indicators tell us about shares of the online pet emporium.

PerkinElmer Should Continue Its Rally to Record Highs in the Months Ahead

Bruce Kamich

Traders should approach PKI from the long side at current levels.

AstraZeneca Is Moving the Needle

Bruce Kamich

This drugmaker is making a historic upside breakout. Let's check the charts.

Why Drugmaker Perrigo Could Surprise on the Upside

Bruce Kamich

PRGO traded up sharply Thursday -- and may not be done.

Load More

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight